These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22037853)

  • 1. Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants.
    Mohamed AF; Nielsen EI; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2012 Jan; 56(1):179-88. PubMed ID: 22037853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling in Preterm Neonates to Guide Gentamicin Dosing Decisions and Predict Antibacterial Effect.
    Neeli H; Hanna N; Abduljalil K; Cusumano J; Taft DR
    J Clin Pharmacol; 2021 Oct; 61(10):1356-1365. PubMed ID: 33945155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
    Nielsen EI; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4619-30. PubMed ID: 21807983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two gentamicin dosing schedules in very low birth weight infants.
    Rastogi A; Agarwal G; Pyati S; Pildes RS
    Pediatr Infect Dis J; 2002 Mar; 21(3):234-40. PubMed ID: 12005088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.
    Barclay ML; Begg EJ; Chambers ST
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1951-7. PubMed ID: 1416886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations.
    van Donge T; Pfister M; Bielicki J; Csajka C; Rodieux F; van den Anker J; Fuchs A
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
    Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
    Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
    Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
    Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
    DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
    Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing.
    Mohamed AF; Cars O; Friberg LE
    J Antimicrob Chemother; 2014 May; 69(5):1350-61. PubMed ID: 24474432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.
    Sundaram A; Alshaikh B; Dersch-Mills D; Dobry J; Akierman AR; Yusuf K
    Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal effect of gentamicin peak concentration provides a rationale for administration of bolus doses.
    McLean AJ; IoannidesDemos LL; Li SC; Bastone EB; Spicer WJ
    J Antimicrob Chemother; 1993 Aug; 32(2):301-5. PubMed ID: 8226432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example.
    Radivoyevitch T; Siranart N; Hlatky L; Sachs R
    AAPS J; 2015 Mar; 17(2):447-56. PubMed ID: 25663652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kill kinetics and regrowth patterns of Escherichia coli exposed to gentamicin concentration-time profiles simulating in vivo bolus and infusion dosing.
    Bastone EB; Li SC; Ioannides-Demos LL; Spicer WJ; McLean AJ
    Antimicrob Agents Chemother; 1993 Apr; 37(4):914-7. PubMed ID: 8494392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Tsuji BT; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and therapeutic monitoring of gentamicin serum concentration in neonates].
    Kaminska E; Piekarczyk A; Prokopczyk J; Zimak J; Sosnowska K; Taljanski W
    Med Wieku Rozwoj; 2001; 5(2):141-7. PubMed ID: 11679678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a dosage individualization table for extended interval gentamicin in neonates beyond the first week of life.
    Dersch-Mills D; Akierman A; Alshaikh B; Sundaram A; Yusuf K
    J Matern Fetal Neonatal Med; 2016; 29(9):1451-6. PubMed ID: 26043646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model.
    Corvec S; Furustrand Tafin U; Betrisey B; Borens O; Trampuz A
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1421-7. PubMed ID: 23295934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates.
    Yu CZ; Myers SR; Faldasz JD
    Pediatr Infect Dis J; 2020 Apr; 39(4):313-317. PubMed ID: 32032171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.